Elutia Inc.(ELUT)Earnings, Financials & Key Ratios
ELUT•NASDAQ
$1.00
$45M mkt cap·0.8× P/E·Price updated May 7, 2026
AboutElutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators. The company also develops CanGarooRM, a combination of the CanGaroo envelope with antibiotics, to reduce the risk of infection after surgical implantation of an electronic device. In addition, it provides ProxiCor for cardiac tissue repair and pericardial closure; Tyke, an extracellular material that is used in the repair of cardiac structures for neonate and infant patients; and VasCure, a patch material to repair or reconstruct the peripheral vasculature. Further, the company offers SimpliDerm, which uses human acellular dermal matrices for tissue repair and reconstruction in various applications, such as sports medicine, hernia repair, trauma reconstruction, and breast reconstruction surgeries following mastectomy. It serves hospitals and healthcare facilities through its direct sales force, independent sales agents, and distributors. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland.Show more
- Revenue$12M-49.6%
- EBITDA-$17M+46.5%
- Net Income$53M+198.9%
- EPS (Diluted)1.29+169.4%
- Gross Margin53.66%+22.2%
- EBITDA Margin-140.23%-6.1%
- Operating Margin-149.78%-2.4%
- Net Margin434.23%+296.2%
- ROE192.9%
- Debt/Equity0.27
ELUT Key Insights
Elutia Inc. (ELUT) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Excellent 3Y average ROE of 192.9%
✗Weaknesses
- ✗Negative free cash flow
- ✗Sales declining 22.0% over 5 years
- ✗Shares diluted 58.0% in last year
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
ELUT Price & Volume
Elutia Inc. (ELUT) stock price & volume — 10-year historical chart
Loading chart...
ELUT Growth Metrics
Elutia Inc. (ELUT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-22.04%
3 Years-19.82%
TTM-49.57%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM198.95%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM133.2%
Return on Capital
10 Years-81.32%
5 Years-121.2%
3 Years-166.49%
Last Year-103.6%
ELUT Peer Comparison
Elutia Inc. (ELUT) competitors in Regenerative Medicine and Tissue Engineering — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 NVCR | 1.92B | 16.83 | -13.80 | 8.28% | -25.66% | -50.82% | 0.85 | |
 XTNT | 79.8M | 0.57 | -4.75 | 28.44% | 1.32% | 3.77% | 0.82 | |
 OSBC | 1.11B | 21.08 | 13.01 | 18.09% | 10.11% | 0.38 | ||
 LMAT | 2.46B | 107.91 | 42.82 | 13.53% | 24.35% | 16.19% | 0.47 | |
 MDT | 99.94B | 77.96 | 21.60 | 3.62% | 13% | 9.45% | 0.59 | |
 ABT | 151.3B | 87.01 | 11.39 | 4.59% | 31.88% | 27.26% | 0.32 | |
 BSX | 84.08B | 56.58 | 29.16 | 19.87% | 14.4% | 12.4% | 0.51 | |
 SYK | 112.69B | 294.25 | 35.03 | 11.16% | 12.92% | 15.04% | 0.66 |
Compare ELUT vs Peers
Elutia Inc. (ELUT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ELUT Income Statement
Elutia Inc. (ELUT) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 39.04M | 42.9M | 42.68M | 47.39M | 23.85M | 24.75M | 24.38M | 12.29M |
| Revenue Growth % | - | 9.9% | -0.51% | 11.03% | -49.68% | 3.76% | -1.5% | -49.57% |
| Cost of Goods Sold | 23.09M | 23.13M | 22.12M | 28.37M | 12.21M | 13.69M | 13.67M | 5.7M |
| COGS % of Revenue | 59.16% | 53.92% | 51.83% | 59.86% | 51.2% | 55.33% | 56.07% | 46.34% |
| Gross Profit | 15.95M▲ 0% | 19.77M▲ 24.0% | 20.56M▲ 4.0% | 19.02M▼ 7.5% | 11.64M▼ 38.8% | 11.05M▼ 5.0% | 10.71M▼ 3.1% | 6.6M▼ 38.4% |
| Gross Margin % | 40.84% | 46.08% | 48.17% | 40.14% | 48.8% | 44.67% | 43.93% | 53.66% |
| Gross Profit Growth % | - | 23.98% | 4.01% | -7.49% | -38.81% | -5.03% | -3.13% | -38.4% |
| Operating Expenses | 24.17M | 28.18M | 34.16M | 42.05M | 46.83M | 41.58M | 46.36M | 25.01M |
| OpEx % of Revenue | 61.9% | 65.68% | 80.03% | 88.74% | 196.35% | 168.03% | 190.19% | 203.43% |
| Selling, General & Admin | 21.68M | 25.78M | 28.21M | 32.51M | 33.9M | 27.19M | 31.2M | 20.84M |
| SG&A % of Revenue | 55.55% | 60.08% | 66.08% | 68.61% | 142.15% | 109.88% | 128.02% | 169.57% |
| Research & Development | 2.48M | 2.4M | 5.95M | 9.27M | 7.73M | 4.4M | 3.79M | 4.16M |
| R&D % of Revenue | 6.36% | 5.59% | 13.95% | 19.55% | 32.4% | 17.78% | 15.53% | 33.86% |
| Other Operating Expenses | 0 | 0 | 0 | 276K | 5.2M | 9.99M | 11.37M | 0 |
| Operating Income | -8.22M▲ 0% | -8.41M▼ 2.3% | -13.6M▼ 61.7% | -23.03M▼ 69.4% | -35.19M▼ 52.8% | -30.53M▲ 13.3% | -35.65M▼ 16.8% | -18.41M▲ 48.4% |
| Operating Margin % | -21.06% | -19.6% | -31.86% | -48.6% | -147.55% | -123.36% | -146.26% | -149.78% |
| Operating Income Growth % | - | -2.29% | -61.72% | -69.37% | -52.78% | 13.25% | -16.79% | 48.35% |
| EBITDA | -4.42M | -4.55M | -9.73M | -19.3M | -31.46M | -27.02M | -32.2M | -17.24M |
| EBITDA Margin % | -11.32% | -10.61% | -22.81% | -40.73% | -131.9% | -109.18% | -132.1% | -140.23% |
| EBITDA Growth % | - | -2.99% | -113.82% | -98.27% | -62.97% | 14.11% | -19.18% | 46.47% |
| D&A (Non-Cash Add-back) | 3.8M | 3.86M | 3.86M | 3.73M | 3.73M | 3.51M | 3.45M | 1.17M |
| EBIT | -6.02M | -6.53M | -16.17M | -19.45M | -31.03M | -35.42M | -49.34M | -18.41M |
| Net Interest Income | -5.52M | -5.38M | -5.63M | -5.32M | -5.12M | -5.8M | -4.78M | 387K |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 5.52M | 5.38M | 5.63M | 5.32M | 5.12M | 5.8M | 4.78M | -387K |
| Other Income/Expense | -3.32M | -3.5M | -8.2M | -1.75M | -959K | -10.7M | -18.47M | 2.55M |
| Pretax Income | -11.54M▲ 0% | -11.91M▼ 3.2% | -21.8M▼ 83.0% | -24.78M▼ 13.7% | -36.15M▼ 45.9% | -41.22M▼ 14.0% | -54.12M▼ 31.3% | -15.86M▲ 70.7% |
| Pretax Margin % | -29.56% | -27.76% | -51.07% | -52.28% | -151.57% | -166.58% | -222.04% | -129% |
| Income Tax | 26K | 30K | 26K | 55K | 34K | 28K | 7K | 13K |
| Effective Tax Rate % | -0.23% | -0.25% | -0.12% | -0.22% | -0.09% | -0.07% | -0.01% | -0.08% |
| Net Income | -11.57M▲ 0% | -11.94M▼ 3.2% | -21.82M▼ 82.8% | -24.83M▼ 13.8% | -32.9M▼ 32.5% | -37.66M▼ 14.5% | -53.95M▼ 43.3% | 53.38M▲ 198.9% |
| Net Margin % | -29.63% | -27.83% | -51.13% | -52.4% | -137.94% | -152.18% | -221.33% | 434.23% |
| Net Income Growth % | - | -3.23% | -82.8% | -13.78% | -32.48% | -14.47% | -43.27% | 198.95% |
| Net Income (Continuing) | -11.57M | -11.94M | -21.82M | -24.83M | -36.18M | -41.25M | -54.13M | -15.87M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 3.29M | 3.59M | 180K | 69.25M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.08▲ 0% | -1.12▼ 3.7% | -2.13▼ 90.2% | -2.38▼ 11.7% | -2.38▲ 0.0% | -2.07▲ 13.0% | -1.86▲ 10.1% | 1.29▲ 169.4% |
| EPS Growth % | - | -3.7% | -90.18% | -11.74% | 0% | 13.03% | 10.14% | 169.35% |
| EPS (Basic) | -1.08 | -1.12 | -2.13 | -2.38 | -2.38 | -2.07 | -1.86 | 1.29 |
| Diluted Shares Outstanding | 10.67M | 10.67M | 10.23M | 10.44M | 13.83M | 18.16M | 29.07M | 45.94M |
| Basic Shares Outstanding | 10.67M | 10.67M | 10.23M | 10.44M | 13.83M | 18.16M | 29.07M | 41.42M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
ELUT Balance Sheet
Elutia Inc. (ELUT) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 18.14M | 18.45M | 59.71M | 47.43M | 50.7M | 31.25M | 26.17M | 55.82M |
| Cash & Short-Term Investments | 2.41M | 2.48M | 39.15M | 30.39M | 16.99M | 19.28M | 13.24M | 36.35M |
| Cash Only | 2.41M | 2.48M | 39.15M | 30.39M | 16.99M | 19.28M | 13.24M | 36.35M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 7.2M | 7.23M | 7.17M | 6M | 17.59M | 5.96M | 7.04M | 6.58M |
| Days Sales Outstanding | 67.32 | 61.5 | 61.28 | 46.18 | 269.16 | 87.9 | 105.36 | 195.37 |
| Inventory | 7.46M | 7.19M | 10.12M | 9.55M | 4.24M | 3.85M | 3.91M | 2.62M |
| Days Inventory Outstanding | 117.89 | 113.45 | 166.93 | 122.93 | 126.75 | 102.71 | 104.44 | 167.67 |
| Other Current Assets | 46K | 108K | 382K | 35K | 11.88M | 2.17M | 1.99M | 10.27M |
| Total Non-Current Assets | 29.61M | 26.33M | 23.1M | 19.74M | 18.14M | 12.18M | 9.96M | 6.53M |
| Property, Plant & Equipment | 870K | 988K | 1.16M | 1.2M | 565K | 504K | 1.68M | 5M |
| Fixed Asset Turnover | 44.87x | 43.42x | 36.73x | 39.49x | 42.21x | 49.10x | 14.49x | 2.46x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 25.26M | 21.86M | 18.47M | 15.07M | 11.67M | 8.27M | 1.53M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 28.74M | 76K | 76K | 76K | 2.51M | 0 | 0 | 0 |
| Total Assets | 47.74M▲ 0% | 44.77M▼ 6.2% | 82.81M▲ 85.0% | 67.17M▼ 18.9% | 68.84M▲ 2.5% | 43.43M▼ 36.9% | 36.13M▼ 16.8% | 62.35M▲ 72.6% |
| Asset Turnover | 0.82x | 0.96x | 0.52x | 0.71x | 0.35x | 0.57x | 0.67x | 0.20x |
| Asset Growth % | - | -6.22% | 84.96% | -18.89% | 2.49% | -36.92% | -16.81% | 72.59% |
| Total Current Liabilities | 13.35M | 18.27M | 26.78M | 26M | 42.62M | 43.04M | 37.8M | 25.14M |
| Accounts Payable | 1.59M | 2.49M | 2.05M | 1.58M | 1.37M | 3.19M | 4.15M | 9.14M |
| Days Payables Outstanding | 25.12 | 39.32 | 33.89 | 20.36 | 41.07 | 85.07 | 110.8 | 585.78 |
| Short-Term Debt | 6.46M | 5.92M | 12.82M | 12.82M | 0 | 3.32M | 1.71M | 4.75M |
| Deferred Revenue (Current) | 0 | 650K | 533K | 5K | 0 | 0 | 0 | 0 |
| Other Current Liabilities | -1.26M | 2.75M | 2.75M | 2.75M | 31.28M | 26.77M | 24.83M | 11.24M |
| Current Ratio | 1.36x | 1.01x | 2.23x | 1.82x | 1.19x | 0.73x | 0.69x | 2.22x |
| Quick Ratio | 0.80x | 0.62x | 1.85x | 1.46x | 1.09x | 0.64x | 0.59x | 2.12x |
| Cash Conversion Cycle | 160.1 | 135.63 | 194.32 | 148.75 | 354.84 | 105.55 | 99 | -222.74 |
| Total Non-Current Liabilities | 77.8M | 81.61M | 35.2M | 27.65M | 31.26M | 38.99M | 44.59M | 9.54M |
| Long-Term Debt | 75.92M | 19.61M | 17.81M | 10.41M | 24.26M | 20.36M | 22.6M | 2.83M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 956K | 0 | 423K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.88M | 61.29M | 16.63M | 16.54M | 6.04M | 18.64M | 21.57M | 6.71M |
| Total Liabilities | 91.15M | 99.88M | 61.98M | 53.65M | 73.87M | 82.03M | 82.39M | 34.68M |
| Total Debt | 82.39M | 25.53M | 30.64M | 23.24M | 25.45M | 23.95M | 24.74M | 7.58M |
| Net Debt | 79.97M | 23.05M | -8.52M | -7.16M | 8.46M | 4.68M | 11.5M | -28.77M |
| Debt / Equity | - | - | 1.47x | 1.72x | - | - | - | 0.27x |
| Debt / EBITDA | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - |
| Interest Coverage | -1.49x | -1.56x | -2.41x | -4.33x | -6.88x | -5.27x | -7.46x | - |
| Total Equity | -43.41M▲ 0% | -55.11M▼ 27.0% | 20.83M▲ 137.8% | 13.52M▼ 35.1% | -5.03M▼ 137.2% | -38.6M▼ 666.9% | -46.26M▼ 19.8% | 27.67M▲ 159.8% |
| Equity Growth % | - | -26.97% | 137.8% | -35.09% | -137.22% | -666.94% | -19.84% | 159.82% |
| Book Value per Share | -4.07 | -5.17 | 2.04 | 1.29 | -0.36 | -2.13 | -1.59 | 0.60 |
| Total Shareholders' Equity | -43.41M | -55.11M | 20.83M | 13.52M | -5.03M | -38.6M | -46.26M | 27.67M |
| Common Stock | 9K | 1K | 10K | 13K | 16K | 23K | 35K | 43K |
| Retained Earnings | -45M | -56.94M | -80.26M | -105.09M | -137.99M | -175.64M | -229.59M | -176.21M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | -56.94M | -80.26M | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ELUT Cash Flow Statement
Elutia Inc. (ELUT) cash flow — operating, investing & free cash flow history
| Line item | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -5.13M | -7.22M | -13.63M | -15.45M | -21.43M | -21.76M | -22.66M | -44.81M |
| Operating CF Margin % | -13.13% | -16.84% | -31.92% | -32.59% | -89.87% | -87.94% | -92.95% | -364.52% |
| Operating CF Growth % | - | -40.98% | -88.6% | -13.36% | -38.77% | -1.53% | -4.12% | -97.78% |
| Net Income | -11.57M | -11.94M | -21.82M | -24.83M | -32.9M | -37.66M | -53.95M | 53.38M |
| Depreciation & Amortization | 3.8M | 3.86M | 3.86M | 3.73M | 3.73M | 3.73M | 3.67M | 1.17M |
| Stock-Based Compensation | 0 | 208K | 779K | 3.54M | 3.65M | 2.44M | 7.89M | 4.4M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13K |
| Other Non-Cash Items | 9.02M | 1.12M | 6.22M | -254K | -1.63M | 661K | 15.64M | -103.77M |
| Working Capital Changes | 1.38M | -467K | -2.67M | 2.38M | 5.71M | 9.07M | 4.09M | 0 |
| Change in Receivables | -1.61M | -30K | 64K | 1.17M | -14.65M | 802K | 527K | 0 |
| Change in Inventory | 1.1M | 269K | -2.93M | 563K | -498K | -609K | -58K | 0 |
| Change in Payables | 352K | -627K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -190K | -577K | -640K | -369K | -540K | 14.21M | -474K | 78.56M |
| Capital Expenditures | -190K | -577K | -640K | -369K | -540K | -346K | -654K | 0 |
| CapEx % of Revenue | 0.49% | 1.34% | 1.5% | 0.78% | 2.26% | 1.4% | 2.68% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 14.55M | 180K | 78.56M |
| Cash from Financing | 6.99M | 7.98M | 51.21M | 6.71M | 8.54M | 9.84M | 17.09M | -10.64M |
| Debt Issued (Net) | -3.96M | 6.73M | 6.98M | -4.53M | 1.62M | -1.96M | -2M | 0 |
| Equity Issued (Net) | 442K | 1000K | 1000K | 1000K | 1000K | -32K | -1000K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | -32K | -1.19M | 0 |
| Other Financing | 10.51M | -1.03M | -2.24M | -2.51M | -3.18M | 11.83M | 20.28M | -10.64M |
| Net Change in Cash | 1.67M▲ 0% | 177K▼ 89.4% | 36.94M▲ 20771.2% | -9.1M▼ 124.6% | -13.44M▼ 47.6% | 2.29M▲ 117.0% | -6.04M▼ 364.0% | 23.11M▲ 482.8% |
| Free Cash Flow | -5.32M▲ 0% | -7.8M▼ 46.8% | -14.27M▼ 82.9% | -15.81M▼ 10.9% | -21.97M▼ 38.9% | -22.11M▼ 0.6% | -23.31M▼ 5.4% | -44.81M▼ 92.2% |
| FCF Margin % | -13.61% | -18.19% | -33.42% | -33.37% | -92.14% | -89.34% | -95.63% | -364.52% |
| FCF Growth % | - | -46.79% | -82.85% | -10.86% | -38.94% | -0.61% | -5.45% | -92.23% |
| FCF per Share | -0.50 | -0.73 | -1.40 | -1.51 | -1.59 | -1.22 | -0.80 | -0.98 |
| FCF Conversion (FCF/Net Income) | 0.44x | 0.61x | 0.62x | 0.62x | 0.65x | 0.58x | 0.42x | -0.84x |
| Interest Paid | 3.47M | 4.4M | 5.11M | 4.98M | 5.48M | 2.32M | 12.69M | 0 |
| Taxes Paid | 16K | 25K | 32K | 0 | 0 | 0 | 0 | 0 |
ELUT Key Ratios
Elutia Inc. (ELUT) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -104.77% | -144.57% | -775.14% | - | - | 192.9% |
| Return on Invested Capital (ROIC) | -16.86% | -280.05% | -82.81% | -184.94% | -539.1% | - | - | - |
| Gross Margin | 40.84% | 46.08% | 48.17% | 40.14% | 48.8% | 44.67% | 43.93% | 53.66% |
| Net Margin | -29.63% | -27.83% | -51.13% | -52.4% | -137.94% | -152.18% | -221.33% | 434.23% |
| Debt / Equity | - | - | 1.47x | 1.72x | - | - | - | 0.27x |
| Interest Coverage | -1.49x | -1.56x | -2.41x | -4.33x | -6.88x | -5.27x | -7.46x | - |
| FCF Conversion | 0.44x | 0.61x | 0.62x | 0.62x | 0.65x | 0.58x | 0.42x | -0.84x |
| Revenue Growth | - | 9.9% | -0.51% | 11.03% | -49.68% | 3.76% | -1.5% | -49.57% |
ELUT Frequently Asked Questions
Elutia Inc. (ELUT) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Elutia Inc. (ELUT) reported $12.3M in revenue for fiscal year 2025. This represents a 69% decrease from $39.0M in 2018.
Elutia Inc. (ELUT) saw revenue decline by 49.6% over the past year.
Yes, Elutia Inc. (ELUT) is profitable, generating $53.4M in net income for fiscal year 2025 (434.2% net margin).
Dividend & Returns
Elutia Inc. (ELUT) has a return on equity (ROE) of 192.9%. This is excellent, indicating efficient use of shareholder capital.
Elutia Inc. (ELUT) had negative free cash flow of $1.4M in fiscal year 2025, likely due to heavy capital investments.
Explore More ELUT
Elutia Inc. (ELUT) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates